Shagun Singh Chadha

CRT reiterated its Buy rating and $150 price target on Edwards Lifesciences Corp (NYSE: EW) Wednesday following the company’s Q4 results. The company’s Q4 revenue grew 15 percent year-over-year to $618 million, beating consensus by by $9 million. EPS was up 12 percent year-over-year...

Wall Street appeared comfortable with the latest big healthcare merger, this one the acquisition of Covidien (NYSE: COV) by Medtronic (NYSE: MDT), a deal which turns eyes to Johnson & Johnson (NYSE: JNJ). "We expect many investors will expect J&J to buy something in the cardiac...

In a report published Tuesday, CRT Capital analyst Shagun Singh Chadha initiated coverage on Intuitive Surgical (NASDAQ: ISRG) with a Sell rating and $305.00 price target. In the report, CRT Capital noted, “Intuitive Surgical develops the da Vinci Surgical System – a robotic-assisted platform...